SOLICITATION NOTICE
66 -- Notice of Intent to Illumina Incorporated
- Notice Date
- 2/15/2024 11:17:34 AM
- Notice Type
- Presolicitation
- NAICS
- 325413
— In-Vitro Diagnostic Substance Manufacturing
- Contracting Office
- NATIONAL INSTITUTES OF HEALTH - CC BETHESDA MD 20892 USA
- ZIP Code
- 20892
- Solicitation Number
- 24-004692
- Response Due
- 2/9/2024 3:30:00 AM
- Archive Date
- 02/23/2024
- Point of Contact
- Shasheshe Goolsby, Phone: 3018274879
- E-Mail Address
-
shasheshe.goolsby@nih.gov
(shasheshe.goolsby@nih.gov)
- Description
- Title NextSeq 500/550 High Output Kit v2.5 (300 Cycles) Reagent kit for the Center of Cellular Engineering at the NIH Clinical Center Product Service Code: 6640 NAICS Code: 325413 Place of Performance: Bethesda, MD 20892 USA POTS: 24-004692 Description This is a notice of intent, NOT a request for a quotation. A solicitation document will NOT be issued, and quotations will NOT be requested. The National Institutes of Health (NIH) intends to award a firm fixed price to Illumina Incorporated of San Diego, California 92122. The purpose of this acquisition is to purchase one NextSeq 500/550 High Output Kit v2.5 (300 Cycles) Reagent kit from Illumina Incorporated. The NextSeq 500/550 High Output Kit v2.5 (300 Cycles) Reagent kit delivers the power of high-throughput sequencing on a benchtop system with increased stability and robustness. The kits deliver powerful sequencing chemistries with as little as 10 minutes of hands-on time. Intuitive labeling and RFID-encoded reagents ensure compatibility with user-defined run configurations. Ready-to-use cartridges redefine ease-of-use. Below are the items needed for this action: Catalog #���������� Description ������������������������� ���������������������������Quantity������������������ ����������������������� 200224908������� NextSeq 500/550 High Output Kit� � � � � � � � � � 1 The proposed vendor, Illumina Incorporated, is the sole manufacturer of these reagent kits. In addition, these kits are the only ones compatible with the NextSeq 550 sequencer currently located in the CCE. This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 � Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available.� Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government. Comments to this announcement, referencing this posting number, may be submitted to the Office of Purchasing and Contracts, prior to the closing date specified in this announcement, electronically to the attention of Shasheshe Goolsby, Lead Contract Specialist, shasheshe.goolsby@nih.gov by February 22, 2023, 6:30AM EST. *** Please send your capability statements ONLY. This IS NOT a request for proposal. ***
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/72232f8859654e22b998cc09ca5034e9/view)
- Place of Performance
- Address: Bethesda, MD 20892, USA
- Zip Code: 20892
- Country: USA
- Zip Code: 20892
- Record
- SN06967992-F 20240217/240215230057 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |